IVD, Diagnostics and Surgical Devices (FDA / EU regulated device makers)
Regulated market (fda 510(k) / pma / establishment registration and clia categorization in ivd + surgical panels; eu ivdr via eudamed) + trade-body membership. The Kin Score Market layer reads each provider in its market: who it integrates with, how deep those integrations go, and where the market publishes its own structure. Methodology.
Where this market publishes its structure
- openFDA device/510k (api.fda.gov, keyless; advisory_committee CH HE IM MI PA TX SU OR, decision_date >= 2016) machine-readable, 11,499 decisions / 3,065 applicants; 70 linked
- openFDA device/pma (same panels, >= 2016) machine-readable, 6,012 decisions (originals + supplements) / 150 applicants; 20 linked
- openFDA device/registrationlisting (owner/operator count by medical specialty, top 1,000 per specialty) machine-readable, 3,586 owner/operators; 60 linked; regulated, no certified products
- FDA CLIA test categorization database (accessdata.fda.gov/premarket/ftparea/clia_detail.zip; the cfClia search page's download) machine-readable, 81,132 rows / 1,060 test-system makers; 33 linked
- EUDAMED public API (ec.europa.eu/tools/eudamed/api devices/udiDiData IVDR + eos manufacturers + actor publicInformation) machine-readable, 95,526 IVDR UDI-DI records / 896 manufacturers; 13 linked; most big makers file under regional legal entities the name check refuses
- AdvaMedDx members (advamed.org/advameddx/members) machine-readable, 65 members with website; 22 linked; 4 held (distributor, contract manufacturer, 2 investors)
- EUDAMED notified-body certificates / actor search by role not machine-readable: eos endpoint 500s without languageIso2Code; certificate data is not in the public actor view (2026-10-21)
- cfClia search.cfm results not machine-readable: a POST form; the same data is published as clia_detail.zip, which was read instead
Own = declares at least one integration itself; covered = visible only because an aggregator, standards body, regulator or partner contract names it; distribution-only = listed only on cloud marketplaces it sells through, a channel reported beside, never counted as its own declared integrations; undeclared = nothing we can read, so no number; declares_compatibility = providers with a `compatible` shape vote, report only (kin, 2026-10-13): never counted as own, never in depth or position.
Taxonomy how this market maps onto apis.io
Derived 2026-10-23 from the 129 providers in this market we could resolve in the catalog. The percentage is the share of those providers carrying each one; it describes the market, not the tag or industry. Tag groups have no page of their own yet, so they are listed unlinked.
| Tags | Healthcare 73%, Medical Devices 48%, Diagnostics 41%, Life Sciences 36% |
|---|---|
| Tag groups | Healthcare 92%, Health 61% |
| Industries | Digital Health & Telehealth 84%, Healthcare 81%, Life Sciences 36%, Biotechnology & Drug Discovery 32% |
share of resolved cohort carrying it; tags >=0.20 & >=3 members (max 12, junk dropped), tag_groups >=0.20 (cooccurrence, non-cross-cutting; max 8), industries >=0.20 (max 6), areas >=0.10 (max 6; areas are keyword-matched and sparse), capabilities L1 >=0.20 (max 8); derive-market-taxonomy.py
Leaders by position (provisional)
Provisional: grouped by position, depth compared within a position only. Distribution (cloud marketplaces) and iPaaS bridges are counted beside position, never inside it. Unknown-builder listings are left out of position shares and counted here.
builds-on 1 · publishes apps on other platforms' stores
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Aignostics | 26.8 thin | 2 | 0 / 2 | 0 | 2 | 0 | builds-on-platform 33%, distribution 67% |
coverage 2 · reaches banks, carriers, systems or channels (an aggregator)
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Epic Systems | 54.7 | 19 | 0 / 19 | 0 | 0 | 0 | contract 16%, standard 21%, coverage 63% |
| Junction | 46.0 | 15 | 0 / 15 | 0 | 0 | 0 | coverage 100% |
regulated 101 · named in a regulator's register or partners' contracts
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Hologic | 67.3 | 11 | 0 / 11 | 0 | 0 | 0 | contract 73%, standard 27% |
| Bio-Rad Laboratories | 66.3 | 8 | 0 / 8 | 0 | 0 | 0 | contract 88%, standard 12% |
| Bioventus | 65.2 | 4 | 0 / 4 | 0 | 0 | 0 | contract 100% |
| Becton Dickinson | 64.4 | 9 | 0 / 9 | 0 | 0 | 0 | contract 78%, standard 22% |
| Healthy.io | 63.9 | 4 | 0 / 4 | 0 | 0 | 0 | contract 100% |
| Abbott Laboratories | 63.6 | 10 | 0 / 10 | 0 | 0 | 0 | contract 80%, standard 20% |
| Intuitive Surgical | 62.6 | 5 | 0 / 5 | 0 | 0 | 0 | contract 100% |
| Dentsply Sirona | 62.1 | 4 | 0 / 4 | 0 | 0 | 0 | contract 100% |
| Medtronic | 61.8 | 13 | 0 / 13 | 0 | 2 | 0 | contract 62%, standard 23%, distribution 15% |
| C. R. Bard | 61.7 | 6 | 0 / 6 | 0 | 0 | 0 | contract 83%, standard 17% |
| AbbVie | 61.6 | 7 | 0 / 7 | 0 | 0 | 0 | contract 57%, standard 43% |
| Andon Health | 61.5 | 6 | 0 / 6 | 0 | 0 | 0 | contract 83%, builds-on-platform 17% |
| Church and Dwight | 61.4 | 5 | 0 / 5 | 0 | 0 | 0 | contract 60%, standard 40% |
| Siemens Healthineers | 61.4 | 6 | 0 / 6 | 0 | 0 | 0 | contract 50%, standard 50% |
| Athelas | 61.3 | 7 | 0 / 7 | 0 | 0 | 0 | contract 86%, standard 14% |
| Auris Health | 61.3 | 3 | 0 / 3 | 0 | 0 | 0 | contract 100% |
| Cytovale | 61.3 | 3 | 0 / 3 | 0 | 0 | 0 | contract 100% |
| restor3d | 61.3 | 3 | 0 / 3 | 0 | 0 | 0 | contract 100% |
| Varian Medical Systems | 61.3 | 8 | 0 / 8 | 0 | 0 | 0 | contract 75%, standard 25% |
| Visby Medical | 61.3 | 3 | 0 / 3 | 0 | 0 | 0 | contract 100% |
| Revvity | 61.2 | 4 | 0 / 4 | 0 | 0 | 0 | contract 100% |
| Agilent Technologies | 60.9 | 9 | 0 / 9 | 0 | 0 | 0 | contract 67%, standard 33% |
| 23andMe | 60.7 | 4 | 0 / 4 | 0 | 0 | 0 | contract 75%, standard 25% |
| Inflammatix | 60.7 | 4 | 0 / 4 | 0 | 0 | 0 | contract 75%, standard 25% |
| Carlsmed | 60.3 | 4 | 0 / 4 | 0 | 0 | 0 | contract 100% |
| Welldoc | 60.0 | 5 | 0 / 5 | 0 | 0 | 0 | contract 80%, standard 20% |
| Foundation Medicine | 59.7 | 3 | 0 / 3 | 0 | 0 | 0 | contract 67%, standard 33% |
| Stryker | 59.6 | 7 | 0 / 7 | 0 | 0 | 0 | contract 71%, standard 29% |
| HistoSonics | 59.4 | 3 | 0 / 3 | 0 | 0 | 0 | contract 67%, standard 33% |
| Thermo Fisher Scientific | 59.2 | 7 | 0 / 7 | 0 | 0 | 0 | contract 71%, standard 29% |
| Adaptive Biotechnologies | 58.9 | 4 | 0 / 4 | 0 | 0 | 0 | contract 75%, standard 25% |
| Pathai | 58.9 | 4 | 0 / 4 | 0 | 0 | 0 | contract 75%, standard 25% |
| Tasso | 58.9 | 4 | 0 / 4 | 0 | 0 | 0 | contract 75%, standard 25% |
| Waters | 58.7 | 4 | 0 / 4 | 0 | 0 | 0 | contract 75%, standard 25% |
| Eli Lilly | 58.5 | 10 | 0 / 10 | 0 | 0 | 0 | contract 50%, standard 50% |
| Data Innovations | 58.2 | 4 | 0 / 4 | 0 | 0 | 0 | contract 50%, standard 50% |
| Tempus AI | 58.1 | 8 | 0 / 8 | 0 | 0 | 0 | contract 75%, standard 25% |
| Johnson & Johnson | 57.9 | 3 | 0 / 3 | 0 | 0 | 0 | contract 67%, standard 33% |
| Dexcom | 57.6 | 11 | 0 / 11 | 0 | 0 | 0 | contract 55%, standard 9%, covered 27%, builds-on-platform 9% |
| Natera | 57.4 | 3 | 0 / 3 | 0 | 0 | 0 | contract 67%, standard 33% |
| Guardant Health | 56.7 | 6 | 0 / 6 | 0 | 0 | 0 | contract 50%, standard 50% |
| Boston Scientific | 56.0 | 6 | 0 / 6 | 0 | 1 | 0 | contract 67%, standard 17%, distribution 17% |
| Solventum | 55.8 | 9 | 0 / 9 | 0 | 1 | 0 | contract 56%, standard 22%, builds-on-platform 11%, distribution 11% |
| Sibel Health | 55.6 | 3 | 0 / 3 | 0 | 0 | 0 | contract 67%, standard 33% |
| Proscia | 52.7 | 7 | 0 / 7 | 0 | 2 | 0 | contract 71%, distribution 29% |
| Illumina | 51.4 | 9 | 0 / 9 | 0 | 1 | 1 | ipaas-bridge 11%, contract 56%, standard 22%, distribution 11% |
| aetherAI | 49.8 | 3 | 0 / 3 | 0 | 0 | 0 | partner-built 33%, contract 67% |
| Baebies | 49.7 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Alere | 44.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Genalyte | 43.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Qure.ai | 43.1 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Cerapedics | 42.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Insightec | 42.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| AggreDyne | 42.1 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Aptitude Medical Systems | 42.1 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Avenda Health | 42.1 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Bigfoot Biomedical | 42.1 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Convergent Dental | 42.1 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Livongo Health | 42.1 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Quest Diagnostics | 42.1 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Sight Diagnostics | 42.1 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Swift Medical | 42.1 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Exact Sciences | 40.1 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Beta Bionics | 39.7 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Binx Health | 39.7 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Biolinq | 39.7 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Elevation Spine | 39.7 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| MiRus | 39.7 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Onkos Surgical | 39.7 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Orthocon | 39.7 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| OSSIO | 39.7 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Shoulder Innovations | 39.7 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Teal Health | 39.7 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| PerkinElmer | 39.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 50%, standard 50% |
| Freenome | 38.8 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 50%, standard 50% |
| Corning | 38.3 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 100% |
| Geneoscopy | 38.2 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 50%, standard 50% |
| Personalis | 38.2 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 50%, standard 50% |
| Acera Surgical | 37.8 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 50%, standard 50% |
| Galvanize Therapeutics | 37.8 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 50%, standard 50% |
| Hyalex Orthopaedics | 37.8 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 50%, standard 50% |
| Zimmer Biomet | 37.8 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 50%, standard 50% |
| AiVita Biomedical | 36.4 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 50%, standard 50% |
| Glooko | 28.8 thin | 2 | 0 / 2 | 0 | 1 | 0 | contract 50%, distribution 50% |
| Boulder Care | 23.9 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| Aerin Medical | 20.6 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| CMR Surgical | 20.6 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| MicroTech Medical | 20.6 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| Signos | 20.6 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| SMTP Technology | 20.6 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| Vertos Medical | 20.6 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| Virtual Incision | 20.6 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| Voom Medical Devices | 20.6 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| Clarapath | 19.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| Clear Labs | 19.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| Everly Health | 19.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| Generation Lab | 19.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| LetsGetChecked | 19.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| Metabolon | 19.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| QuidelOrtho | 19.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
| Simple HealthKit | 19.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
standard 13 · listed by a voluntary standard's own directory
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| WellSky | 60.0 | 3 | 0 / 3 | 0 | 0 | 0 | contract 33%, standard 67% |
| GE HealthCare Technologies | 58.3 | 7 | 0 / 7 | 0 | 0 | 0 | contract 29%, standard 71% |
| Roche | 56.4 | 7 | 0 / 7 | 0 | 0 | 0 | contract 29%, standard 71% |
| Philips | 51.4 | 10 | 0 / 10 | 0 | 1 | 0 | standard 60%, builds-on-platform 20%, distribution 10%, atp-outside 10% |
| Invitae | 48.5 | 4 | 0 / 4 | 0 | 1 | 0 | contract 25%, standard 50%, distribution 25% |
| Mercy BioAnalytics | 34.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | standard 100% |
| MyOme | 34.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | standard 100% |
| Genialis | 26.8 thin | 2 | 0 / 2 | 0 | 1 | 0 | standard 50%, distribution 50% |
| Artera Decisionrisk Analysis | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| Color | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| Danaher | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| Grail | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| LI-COR Intermediate | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
undeclared 12 · declares nothing we can read: no number
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Element Biosciences | undeclared | - | - | - | - | - | |
| Elysium Health | undeclared | - | - | - | - | - | |
| LinusBio | undeclared | - | - | - | - | - | |
| Liquid Instruments | undeclared | - | - | - | - | - | |
| Opentrons | undeclared | - | - | - | - | - | |
| Phi Longevity | undeclared | - | - | - | - | - | |
| Picarro | undeclared | - | - | - | - | - | |
| Slingshot Biosciences | undeclared | - | - | - | - | - | |
| Strand AI | undeclared | - | - | - | - | - | |
| Thriva | undeclared | - | - | - | - | - | |
| Uncovr | undeclared | - | - | - | - | - | |
| Watchmaker Genomics | undeclared | - | - | - | - | - |
Generated 2026-10-24 from API Evangelist's own files; nothing on this page is a model's judgement. Provisional and unweighted; not part of the Kin Score composite or agent readiness. Read the Market layer methodology. Disagree with an edge? Every edge cites its evidence and can be corrected through the normal correction path.